Medindia

X

VIVUS Announces Positive Phase 3 Results of Avanafil in Radical Prostatectomy Patients

Wednesday, May 25, 2011 General News J E 4
Advertisement
Top-line Results Show Significant Improvement in Erectile Function in Difficult-to-Treat Patients

CONTACT:

VIVUS, Inc.

Investor Relations:

The Trout Group

Timothy E. Morris

Brian Korb

Chief Financial Officer

646-378-2923

650-934-5200

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Cambridge Temperature Concepts Wins Prestigious Aw...
S
Medivance Named to Mercury 100 Ranking of the 100 ...